540 related articles for article (PubMed ID: 32579791)
1. Crossroads of telomere biology and anticancer drug discovery.
Seimiya H
Cancer Sci; 2020 Sep; 111(9):3089-3099. PubMed ID: 32579791
[TBL] [Abstract][Full Text] [Related]
2. Potential Telomere-Related Pharmacological Targets.
Berei J; Eckburg A; Miliavski E; Anderson AD; Miller RJ; Dein J; Giuffre AM; Tang D; Deb S; Racherla KS; Patel M; Vela MS; Puri N
Curr Top Med Chem; 2020; 20(6):458-484. PubMed ID: 31916516
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage/dysfunction and cell death.
Liu R; Liu J; Wang S; Wang Y; Zhang T; Liu Y; Geng X; Wang F
Cell Death Dis; 2019 Jul; 10(7):527. PubMed ID: 31296842
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.
Yuan X; Larsson C; Xu D
Oncogene; 2019 Aug; 38(34):6172-6183. PubMed ID: 31285550
[TBL] [Abstract][Full Text] [Related]
5. Anticancer therapy targeting telomeres and telomerase : current status.
Parkinson EK; Minty F
BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in targeting the telomeric G-quadruplex DNA sequence with small molecules as a strategy for anticancer therapies.
Islam MK; Jackson PJ; Rahman KM; Thurston DE
Future Med Chem; 2016 Jul; 8(11):1259-90. PubMed ID: 27442231
[TBL] [Abstract][Full Text] [Related]
7. Telomere maintenance as a target for drug discovery.
Sekaran V; Soares J; Jarstfer MB
J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596
[TBL] [Abstract][Full Text] [Related]
8. Chemical targeting of G-quadruplexes in telomeres and beyond for molecular cancer therapeutics.
Seimiya H; Nagasawa K; Shin-Ya K
J Antibiot (Tokyo); 2021 Oct; 74(10):617-628. PubMed ID: 34285374
[TBL] [Abstract][Full Text] [Related]
9. TERT promoter mutations in telomere biology.
Heidenreich B; Kumar R
Mutat Res Rev Mutat Res; 2017; 771():15-31. PubMed ID: 28342451
[TBL] [Abstract][Full Text] [Related]
10. Methods of studying telomere damage induced by quadruplex-ligand complexes.
Rizzo A; Salvati E; Biroccio A
Methods; 2012 May; 57(1):93-9. PubMed ID: 22410593
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Raymond E; Faivre S; Dieras V; Von Hoff D
Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
[TBL] [Abstract][Full Text] [Related]
12. Research Progress on G-Quadruplexes in Human Telomeres and Human Telomerase Reverse Transcriptase (hTERT) Promoter.
Gu W; Lin Z; Zhao S; Wang G; Shen Z; Liu W; Cai Y; Wang K; Wan CC; Yan T
Oxid Med Cell Longev; 2022; 2022():2905663. PubMed ID: 35707279
[TBL] [Abstract][Full Text] [Related]
13. G-quadruplex stabilizer Tetra-Pt(bpy) disrupts telomere maintenance and impairs FAK-mediated migration of telomerase-positive cells.
Shen Z; Zheng R; Yang H; Xing S; Jin X; Yan H; Zhu J; Mei Y; Lin F; Zheng X
Int J Biol Macromol; 2022 Jul; 213():858-870. PubMed ID: 35697164
[TBL] [Abstract][Full Text] [Related]
14. Agents that target telomerase and telomeres.
Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
[TBL] [Abstract][Full Text] [Related]
15. Oligonucleotides and G-quadruplex stabilizers: targeting telomeres and telomerase in cancer therapy.
Crees Z; Girard J; Rios Z; Botting GM; Harrington K; Shearrow C; Wojdyla L; Stone AL; Uppada SB; Devito JT; Puri N
Curr Pharm Des; 2014; 20(41):6422-37. PubMed ID: 24975605
[TBL] [Abstract][Full Text] [Related]
16. Telomere length maintenance in aging and carcinogenesis.
Aragona M; Maisano R; Panetta S; Giudice A; Morelli M; La Torre I; La Torre F
Int J Oncol; 2000 Nov; 17(5):981-9. PubMed ID: 11029502
[TBL] [Abstract][Full Text] [Related]
17. Revisiting Telomere Shortening in Cancer.
Okamoto K; Seimiya H
Cells; 2019 Jan; 8(2):. PubMed ID: 30709063
[TBL] [Abstract][Full Text] [Related]
18. Computational tools in the discovery of new G-quadruplex ligands with potential anticancer activity.
Castillo-González D; Pérez-Machado G; Pallardó F; Garrigues-Pelufo TM; Cabrera-Pérez MA
Curr Top Med Chem; 2012; 12(24):2843-56. PubMed ID: 23368106
[TBL] [Abstract][Full Text] [Related]
19. [Telomeres and telomerase, new targets for anticancer chemotherapy].
Riou JF; Morjani H; Trentesaux C
Ann Pharm Fr; 2006 Mar; 64(2):97-105. PubMed ID: 16568010
[TBL] [Abstract][Full Text] [Related]
20. Telomerase Biology Associations Offer Keys to Cancer and Aging Therapeutics.
Smith-Sonneborn J
Curr Aging Sci; 2020; 13(1):11-21. PubMed ID: 31544708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]